New 3-D method could help grow cancer cells from a simple blood draw
NCT ID NCT05623748
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This completed study tested a 3-D cell culture method to isolate and grow circulating tumor cells (CTCs) from blood samples of 160 people with and without cancer. The goal was to see if this method could reliably expand CTC numbers for research. If it works, it could improve how scientists study cancer spread and test new drugs.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this method could help researchers grow cancer cells from blood samples, making it easier to study cancer spread and test drugs.
- What could go wrong
- This is an early observational study focused on lab methods, not a treatment. It may not lead to direct patient benefits or work for all cancer types.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
160 people
The number who actually took part.
- Started
-
Aug 2021
- Finished
-
Aug 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
cancer patients with transitional cell carcinoma
- Ages
-
20 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. patients who agreed with the content of informed consent of the study protocol 2. patients who agreed the researcher to review the medical record 3. adults \>20 years old 4. Patients have the right to asked withdrawing from the trial at any timepoints 5. meet the following requirements (1)cancer participants:cancer patients with transitional cell carcinoma (2)healthy participants:participants without cancer Exclusion Criteria: 1. Patients who refused the collection of blood and the reviewing of medical record 2. The investigators suggest to withdraw
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cell carcinoma are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Chang Gung Memorial Hospital
New Taipei City, 236, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.